Veerhealth Care has unveiled Ambitious Expansion Project to Enhance Healthcare Solutions with a proposed investment of Rs 33 crore. This investment encompasses various aspects including the acquisition of land, construction of buildings, procurement of plant and machinery, and development of essential infrastructure. To facilitate this expansion, VeerHealth Care will be raising Rs 8 crore through bank borrowings. Additionally, the Board of Directors has approved a strategic move to issue new equity shares to further bolster financial resources.
VeerHealth Care will issue 99,99,238 new equity shares at Rs 25 per share including a premium of Rs 15 per share. This right Issue is offered in the ratio of 1:2 i.e. one equity share is offered for every two shares held by existing shareholders including promoters in the Company. This strategic initiative not only fortifies the company's financial position but also underscores its commitment to maximizing value for its shareholders. The expansion project marks a significant milestone in its journey towards excellence in healthcare services.
Veerhealth Care is engaged mainly in business of trading and manufacturing and marketing research based ayurvedic medicines.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |